DnB Asset Management AS Has $58.27 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• DnB Asset Management AS increased its stake in Intuitive Surgical by 17.0% during the 1st quarter, owning 117,652 shares valued at approximately $58.27 million.
• Institutional investors own 83.64% of Intuitive Surgical's stock, with several significant investors, including Vanguard and Invesco, expanding their holdings during the same period.
• Analysts are generally optimistic about Intuitive Surgical, with 13 rating it as a Buy and an average target price of $595.95, despite some mixed recent analyst ratings.

DnB Asset Management AS increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 117,652 shares of the medical equipment provider's stock after acquiring an additional 17,121 shares during the period. DnB Asset Management AS's holdings in Intuitive Surgical were worth $58,270,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Eventide Asset Management LLC boosted its position in shares of Intuitive Surgical by 1.2% during the 1st quarter. Eventide Asset Management LLC now owns 58,313 shares of the medical equipment provider's stock worth $28,876,000 after acquiring an additional 701 shares in the last quarter. Clark Capital Management Group Inc. acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $635,000. Belmont Capital LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $594,000. AQR Capital Management LLC boosted its position in Intuitive Surgical by 51.5% in the first quarter. AQR Capital Management LLC now owns 50,906 shares of the medical equipment provider's stock valued at $24,594,000 after buying an additional 17,314 shares in the last quarter. Finally, Advisors Asset Management Inc. grew its stake in shares of Intuitive Surgical by 34.5% during the first quarter. Advisors Asset Management Inc. now owns 21,514 shares of the medical equipment provider's stock worth $10,655,000 after buying an additional 5,517 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ISRG. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. UBS Group boosted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Truist Financial boosted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Trading Up 0.7%

ISRG stock traded up $3.14 during midday trading on Monday, hitting $470.00. The stock had a trading volume of 1,936,330 shares, compared to its average volume of 2,023,255. The firm has a market cap of $168.49 billion, a P/E ratio of 65.55, a price-to-earnings-growth ratio of 4.89 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a fifty day moving average price of $494.00 and a two-hundred day moving average price of $512.08.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.